CNBX Pharmaceuticals Inc. (CNBX) Non Operating Income (2015 - 2018)

CNBX Pharmaceuticals (CNBX) has 4 years of Non Operating Income data on file, last reported at -$7685.0 in Q4 2018.

• Quarterly Non Operating Income fell 1289.69% year-over-year to -$7685.0 in Q4 2018, while the trailing twelve-month figure through Nov 2018 was $38124.0 (up 249.85% YoY) and the FY2017 annual result came in at -$69027.0, down 147.5% from the prior year.
• Non Operating Income grew to -$7685.0 in Q4 2018, from -$20017.0 in the prior quarter.
• In the past five years, Non Operating Income ranged from a high of $227448.0 in Q2 2017 to a low of -$245755.0 in Q1 2017.
• A 4-year average of -$4755.4 and a median of -$6581.0 in 2017 frame the typical range for Non Operating Income.
• The widest YoY moves for Non Operating Income: up 1900.14% in 2017, down 2451.44% in 2017.
• Tracing CNBX's Non Operating Income over 4 years: stood at -$2319.0 in 2015, then slumped by 1803.32% to -$44138.0 in 2016, then surged by 98.75% to -$553.0 in 2017, then plunged by 1289.69% to -$7685.0 in 2018.
• The last three Non Operating Income figures came in at -$7685.0 (Q4 2018), -$20017.0 (Q2 2018), and $66379.0 (Q1 2018), per Business Quant data.